New York Times Feature Article of n-Lorem
https://www.nytimes.com/2022/12/19/health/rare-disease-genetic-treatments.html
Baylor College of Medicine welcomes 10 new leaders to the Board of Advisors
https://www.bcm.edu/news/baylor-college-of-medicine-welcomes-10-new-leaders-to-the-board-of-advisors
BioSpace Article Giving Hope Silence ALS
San Diego Union Tribune Feature Article of n-Lorem
The G Word: Dr Stanley Crooke: Advancing the health of human beings around the world
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 10
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 9
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 8
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 7
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 6
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 5
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 4
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 3, featuring Founding Donor Rosanne M. Crooke, PhD
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series Part 2
Nature Biotechnology premiered Hope Lies in Dream – 10-part weekly series beginning with n-Lorem’s founder Stanley T. Crooke, MD, PhD Part 1
Helping the Patients He Can. For Free. For Life. – Stanley Crooke, MD, PhD
N-Lorem Founder Discusses Advancements in Genome Sequencing, Newborn Screening, Regulatory Approaches, and Collaboration with Patients

An Antisense Pioneer Brings Custom Treatments to Patients with Ultra-Rare Conditions
Stan Crooke on Ultra Rare Disease Drugs
Driving N-of-1 Therapies for Ultra-Rare Disease Patients
Hope for Ultra-Rare Diseases
First Rounders: Stan Crooke